Abstract

analog scale (VAS). Quality of life (QoL) was evaluated using question 8 of the International Prostate Symptoms Score. Secondary safety end points: Uroflowmetry followed by post void urine volume measurement and kidney ultrasound were done after the treatment. RESULTS: The results of the study are presented in the Table 1. CONCLUSIONS: Trigonal injection of 100 U BTX-A shows similar efficacy comparing to conventional bladder hydrodistention. There are no significant increase on the amount of residual urine, no decrease in urolowmtry rate and no upper urinary tract retention. Therefore, longer term follow up studies are warranted.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call